IV Ketamine vs At-Home Ketamine: Comparing Clinic and Home-Based Treatment

Overview

The expansion of ketamine therapy beyond traditional clinic settings has created a meaningful choice for patients: receive IV infusions under direct clinical supervision, or participate in an at-home program with telehealth oversight and self-administered sublingual medication. Both approaches have produced positive outcomes for depression, anxiety, and other conditions, but they differ substantially in how treatment is delivered, what the experience feels like, and what they cost.

Understanding these differences helps you choose the option that best fits your clinical needs, lifestyle, and financial situation. Neither option is categorically superior — the right choice depends on your specific circumstances. For patient perspectives on both approaches, read about the IV infusion experience and the at-home ketamine experience.

How Each Option Works

IV Ketamine Infusions

IV ketamine is administered directly into the bloodstream through an intravenous catheter at a specialized clinic. A nurse or physician controls the infusion rate, typically delivering the medication over 40 to 60 minutes. Vital signs are monitored continuously. The standard initial protocol involves six infusions spread over two to three weeks, followed by maintenance infusions as needed.

At-Home Ketamine Programs

At-home programs pair you with a prescribing provider via telehealth who evaluates you, prescribes sublingual ketamine (tablets or troches), and ships the medication to your home from a licensed compounding pharmacy. You self-administer the medication at home during scheduled sessions, typically with a telehealth check-in before or during the experience. A treatment companion may be required to be present.

Effectiveness

IV Ketamine

IV infusions deliver ketamine with approximately 100 percent bioavailability, meaning virtually all of the medication reaches your bloodstream. This allows for precise therapeutic dosing and consistent plasma levels. The research base for IV ketamine is the most robust of any administration route, with response rates for treatment-resistant depression consistently reported between 60 and 70 percent.

At-Home Ketamine

Sublingual ketamine has a bioavailability of roughly 25 to 35 percent, which means higher nominal doses are required to achieve therapeutic levels. While fewer large-scale clinical trials have focused specifically on sublingual ketamine compared to IV, real-world data and emerging studies show meaningful response rates. Many patients achieve significant symptom improvement through at-home programs, though the evidence base is not yet as mature as for IV treatment.

Safety and Medical Supervision

IV Ketamine

In-clinic infusions provide the highest level of medical oversight. Vital signs are monitored throughout treatment, a clinician is physically present, and emergency medical equipment and medications are immediately available. Blood pressure elevations — the most common medical concern during ketamine treatment — can be detected and addressed in real time. This level of supervision makes IV infusions the most appropriate choice for patients with cardiovascular risk factors or complex medical histories.

At-Home Ketamine

At-home programs rely on thorough upfront screening and remote monitoring. During sessions, supervision may involve a real-time telehealth video check-in, a phone call, or an asynchronous check-in after the session. While reputable programs require a treatment companion to be present and provide emergency protocols, the level of medical oversight is inherently lower than in a clinical setting. For patients without significant medical risk factors, this level of supervision is generally considered appropriate by prescribing clinicians.

Cost Comparison

The cost difference is substantial and is often the primary factor driving patients toward at-home options. At-home programs can cost one-quarter to one-fifth of what IV infusions cost over the course of a year.

Convenience and Accessibility

IV Ketamine

IV infusions require traveling to a specialized clinic, which may not exist within a reasonable distance for many patients — particularly those in rural areas. Each visit requires several hours including travel, preparation, treatment, and recovery. You need someone to drive you home after every session. For the initial series of six sessions over two to three weeks, this represents a significant time and logistical commitment.

At-Home Ketamine

At-home treatment eliminates travel entirely. You can schedule sessions at times that work for your life, receive treatment in the comfort of your own home, and avoid the logistical burden of repeated clinic visits. For patients with mobility limitations, caregiving responsibilities, demanding work schedules, or limited access to clinics, at-home treatment can make the difference between receiving care and not receiving care at all.

The Treatment Experience

IV Ketamine

The IV experience tends to produce a more intense and consistent dissociative experience due to the higher bioavailability and the controlled rate of delivery. Many patients describe IV sessions as deeply immersive, with more pronounced perceptual changes and emotional processing. The clinical environment, with its monitoring equipment and medical staff, provides a sense of safety that some patients find reassuring and others find clinical or sterile.

At-Home Ketamine

The sublingual experience is generally milder and more gradual in onset. Some patients prefer this gentler approach, while others feel that the lower intensity limits the therapeutic depth of the experience. Being in your own home can feel more comfortable and private, but it also means you do not have the immediate reassurance of a medical professional in the room. The quality of the experience often depends on how thoughtfully you set up your environment.

Who Should Choose Which Option

IV ketamine may be the better choice if you:

• Have severe or acute symptoms requiring the most evidence-backed approach
• Have complex medical conditions that benefit from direct monitoring
• Prefer the reassurance of in-person clinical supervision
• Have access to a reputable clinic within reasonable distance
• Can manage the higher cost

At-home ketamine may be the better choice if you:

• Do not have access to a nearby ketamine clinic
• Need a more affordable long-term treatment option
• Have work, family, or mobility constraints that make repeated clinic visits difficult
• Have already been screened and deemed a straightforward candidate without significant medical risk factors
• Prefer the comfort and privacy of your own space

Combining Both Approaches

Some patients use a combined approach: starting with IV infusions for the initial treatment series (taking advantage of the higher bioavailability and clinical supervision during the most critical early phase), then transitioning to at-home sublingual ketamine for ongoing maintenance. This approach balances clinical rigor with long-term affordability and convenience.

References

• Andrade C. Oral ketamine for depression. Journal of Clinical Psychiatry, 2019. — Review of evidence for oral and sublingual ketamine as a treatment for depression
• Corriger A, Pickering G. Ketamine and depression: a narrative review. Drug Design, Development and Therapy, 2019. — Comprehensive narrative review comparing ketamine routes of administration
• Zarate CA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant depression. Archives of General Psychiatry, 2006. — Foundational RCT establishing IV ketamine efficacy for treatment-resistant depression
• Smith-Apeldoorn SY, et al. Maintenance ketamine treatment for depression. British Journal of Psychiatry, 2022. — Evidence on long-term ketamine treatment approaches
• Ketamine for depression. National Institute of Mental Health (NIMH). — Federal overview of ketamine as a depression treatment